Table 1 Clinical characteristics of early-stage NSCLC patients, healthy controls (HC) and patients with benign lung disease (LBD) enrolled in this study.

From: Simultaneous quantification of serum monounsaturated and polyunsaturated phosphatidylcholines as potential biomarkers for diagnosing non-small cell lung cancer

Characteristic

Non-targeted metabolomics

Targeted metabolomics

NSCLC patients

HC

NSCLC patients

HC

Sample size

90

90

30

30

Age range (years)

58.1 ± 9.0

53.0 ± 11.8

62.1 ± 6.7

51.7 ± 7.1

Sex

  Male

40

42

21

19

  Female

50

48

9

11

Pathological type

  ADCa

50

—

15

—

  SqCCb

30

—

15

—

TNM stagec

  Stage I

81

—

15

—

  Stage II

9

—

15

—

  1. aADC: Adenocarcinoma.
  2. bSqCC: Squamous cell carcinoma.
  3. cUnion for International Cancer Control (UICC) TNM Classification of lung cancer (8th ed., 2017).
Back to article page